PRA Health Sciences nomeia alto funcionário da FDA para liderar o novo Centro Global de Excelência da Estratégia de Testes Clínicos Descentralizados
November 23, 2020 14:28 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences, Inc. (NASDAQ: PRAH) anunciou hoje a nomeação de Isaac Rodriguez-Chávez, PhD, MHS, MS, como Vice-Presidente Sênior, Assuntos...
PRA Health Sciences nomme un haut responsable de la FDA pour diriger le nouveau Centre mondial d'excellence pour la stratégie d'essais cliniques décentralisés
November 23, 2020 14:28 ET
|
PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 23 nov. 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd'hui la nomination d'Isaac Rodriguez-Chavez, PhD, MHS, MME, au poste de...
PRA Health Sciences 任命高級 FDA 官員領導新全球分散式臨床試驗策略卓越中心
November 23, 2020 14:28 ET
|
PRA Health Sciences, Inc.
北卡羅萊納州拉里格, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) 今天宣佈任命 Isaac Rodriguez-Chavez 博士、環境健康科學碩士兼理學碩士為科學和臨床事務高級副總裁。他將領導公司的全球分散式臨床試驗策略卓越中心。Rodriguez-Chavez 博士的職責包括實現...
PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy
November 19, 2020 16:02 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C. , Nov. 19, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the appointment of Isaac Rodriguez-Chavez, PhD, MHS, MS, as Senior Vice President,...
PRA Health Sciences, Inc. Reports Third Quarter 2020 Results and Updates Full Year 2020 Guidance
November 04, 2020 16:01 ET
|
PRA Health Sciences, Inc.
Net new business of $737.9 million; representing growth of 10.2%; Net book-to-bill of 1.28 excluding reimbursement revenueNet new business of $986.0 million; Net book-to-bill of 1.35 including...
PRA Health Sciences to Report Third Quarter 2020 Earnings
October 07, 2020 17:09 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its third quarter 2020 results after the market closes on Wednesday, November 4, 2020. The...
PRA 헬스사이언스, BARDA로부터 임상 연구 네트워크 회원사로 선정
October 07, 2020 11:10 ET
|
PRA Health Sciences, Inc.
미국 노스캐롤라이나주 롤리, Oct. 08, 2020 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ:PRAH))는 미국 생물의약품첨단연구개발국(BARDA)으로부터 업데이트된 임상연구 네트워크(Clinical Studies Network) 회원사로 등록되었다고 밝혔다. 임상시험 계획 및...
PRA Health Sciences von BARDA als Mitglied des exklusiven Clinical Studies Network ausgewählt
October 07, 2020 11:10 ET
|
PRA Health Sciences, Inc.
Mit dem neuen Vertrag wird PRA die Biomedical Advanced Research and Development Authority (BARDA) bei der Entwicklung medizinischer Maßnahmen für die öffentliche Gesundheit unterstützen RALEIGH,...
PRA Health Sciences sélectionnée par la BARDA pour intégrer son réseau d'études cliniques exclusif
October 07, 2020 11:10 ET
|
PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 07 oct. 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd'hui avoir été sélectionnée par la Biomedical Advanced Research and Development...
BARDA 選擇 PRA Health Sciences 作為為其專屬臨床研究網絡的成員
October 07, 2020 11:10 ET
|
PRA Health Sciences, Inc.
新澤西州拉里市, Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) 今天宣佈公司已獲生物醫學高級研究和開發管理局 (BARDA) 選為最新臨床研究網絡 (CSN) 的成員。PRA 獲授予臨床試驗計劃和執行 (CTPE)...